Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solution services in Hong Kong. More Details
Flawless balance sheet and good value.
Share Price & News
How has Bamboos Health Care Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2293 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 2293's weekly volatility (5%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 2293 matched the Hong Kong Healthcare industry which returned -17.9% over the past year.
Return vs Market: 2293 underperformed the Hong Kong Market which returned 7.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Bamboos Health Care Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StHere's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital
4 weeks ago | Simply Wall StBamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
1 month ago | Simply Wall StWe Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential
Is Bamboos Health Care Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2293 (HK$0.83) is trading below our estimate of fair value (HK$3.99)
Significantly Below Fair Value: 2293 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2293 is good value based on its PE Ratio (10.8x) compared to the HK Healthcare industry average (20.6x).
PE vs Market: 2293 is good value based on its PE Ratio (10.8x) compared to the Hong Kong market (11.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2293's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2293 is overvalued based on its PB Ratio (2.2x) compared to the HK Healthcare industry average (1.5x).
How is Bamboos Health Care Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bamboos Health Care Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Bamboos Health Care Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Bamboos Health Care Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Bamboos Health Care Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2293 has high quality earnings.
Growing Profit Margin: 2293's current net profit margins (40.2%) are lower than last year (47.6%).
Past Earnings Growth Analysis
Earnings Trend: 2293's earnings have grown by 9.3% per year over the past 5 years.
Accelerating Growth: 2293's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 2293 had negative earnings growth (-21.2%) over the past year, making it difficult to compare to the Healthcare industry average (-9.1%).
Return on Equity
High ROE: 2293's Return on Equity (20%) is considered high.
How is Bamboos Health Care Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 2293's short term assets (HK$131.4M) exceed its short term liabilities (HK$25.9M).
Long Term Liabilities: 2293's short term assets (HK$131.4M) exceed its long term liabilities (HK$2.7M).
Debt to Equity History and Analysis
Debt Level: 2293 is debt free.
Reducing Debt: 2293 has no debt compared to 5 years ago when its debt to equity ratio was 7.9%.
Debt Coverage: 2293 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2293 has no debt, therefore coverage of interest payments is not a concern.
What is Bamboos Health Care Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 2293's dividend (6.02%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.13%).
High Dividend: 2293's dividend (6.02%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.66%).
Stability and Growth of Payments
Stable Dividend: 2293 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 2293's dividend payments have increased, but the company has only paid a dividend for 6 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (65.2%), 2293's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Winsome Hai (49 yo)
Ms. Hiu Chu Hai, also known as Winsome, serves as the Chief Executive Officer of Bamboos Health Care Holdings Limited and serves as its Executive Director from March 28, 2014. She serves as the Chairman of...
CEO Compensation Analysis
Compensation vs Market: Winsome's total compensation ($USD401.75K) is above average for companies of similar size in the Hong Kong market ($USD230.12K).
Compensation vs Earnings: Winsome's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|CEO & Chairman||no data||HK$3.12m||67.5% |
|Independent Non-Executive Director||1.83yrs||HK$166.00k||no data|
|Independent Non-Executive Director||2yrs||HK$289.00k||no data|
|Independent Non-Executive Director||2.42yrs||HK$165.00k||no data|
|Independent Non-Executive Director||1.75yrs||HK$166.00k||no data|
|Advisor to the Executive Board||0.083yr||no data||no data|
Experienced Board: 2293's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Bamboos Health Care Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Bamboos Health Care Holdings Limited
- Ticker: 2293
- Exchange: SEHK
- Founded: 2009
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: HK$332.000m
- Shares outstanding: 400.00m
- Website: https://www.bamboos.com.hk
Number of Employees
- Bamboos Health Care Holdings Limited
- Wing On Plaza
- 2nd Floor
- Tsim Sha Tsui
- Hong Kong
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|2293||SEHK (The Stock Exchange of Hong Kong Ltd.)||Yes||Ordinary Shares||HK||HKD||Jul 2014|
Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solution services in Hong Kong. It offers 24-hour private nursing services; home care and consultation solu...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/16 10:21|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.